0001209191-23-038345.txt : 20230620
0001209191-23-038345.hdr.sgml : 20230620
20230620161044
ACCESSION NUMBER: 0001209191-23-038345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fotopoulos Alexandros
CENTRAL INDEX KEY: 0001799814
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 231025138
MAIL ADDRESS:
STREET 1: TWO COMMERCE SQUARE, 2001 MARKET STREET
STREET 2: 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001787297
Passage BIO, Inc.
PASG
0001799814
Fotopoulos Alexandros
ONE COMMERCE SQUARE
2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA
PA
19103
0
1
0
0
Chief Technical Officer
0
Common Stock
2023-06-15
4
M
0
12500
0.00
A
32745
D
Common Stock
2023-06-16
4
S
0
4052
0.9325
D
28693
D
Restricted Stock Units
2023-06-15
4
M
0
12500
0.00
D
Common Stock
12500
25000
D
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
1/4 of the RSUs vested on June 15, 2022, and the remainder vested or vests as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
/s/ Edgar Cale, Attorney-in-Fact
2023-06-20